Assessment of retinal function before and after idiopathic macular hole surgery

ISRCTN ISRCTN31177220
DOI https://doi.org/10.1186/ISRCTN31177220
Protocol serial number N/A
Sponsor Catholic University of Sacro Cuore (Italy)
Funder Catholic University of Sacro Cuore (Italy)
Submission date
14/11/2012
Registration date
27/11/2013
Last edited
27/11/2013
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Idiopathic macular hole (a small gap that opens up at the centre of the retina, in an area called the macula) causes central vision loss in the elderly. The aim of the study is to assess the effectiveness and safety of pars plana vitrectomy (a surgical procedure that involves removal of vitreous gel from the eye) and internal limiting membrane peeling assisted by intravitreal injection of triamcinolone acetonide or infracyanine green.

Who can participate?
Patients of any age and gender affected by full thickness idiopathic macular hole can participate.

What does the study involve?
Patients are randomly allocated to one of two groups. One group is treated with pars plana vitrectomy and internal limiting membrane peeling assisted by intravitreal injection of triamcinolone acetonide. The second group is treated with pars plana vitrectomy and internal limiting membrane peeling assisted by intravitreal injection of infracyanine green. Retinal function is assessed in patients of both groups before and after the operation.

What are the possible benefits and risks of participating?
The expected benefits of surgical treatment are the closure of the hole with improvement in vision. Possible risks related to the surgical procedure are eye infection, vitreous haemorrhage (leakage of blood into the areas in and around the vitreous humor of the eye), retinal tears and/or detachment.

Where is the study run from?
Department of Opthalmology, Catholic University of Sacro Cuore (Italy).

When is the study starting and how long is it expected to run for?
The study started in December 2010 and the study ran until July 2012.

Who is funding the study?
Catholic University of Sacro Cuore (Italy)

Who is the main contact?
Dr Edoardo Abed

Contact information

Dr Edoardo Abed
Scientific

Largo Agostino Gemelli
8 Department of Ophthalmology Catholic University of Sacro Cuore
Rome
00168
Italy

Study information

Primary study designInterventional
Study designRandomised interventional treatment trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleAssessment of retinal function before and after idiopathic macular hole surgery: a randomised trial
Study objectivesTo compare functional outcomes of vitrectomy and internal limiting membrane peeling assisted by intravitreal injection of triamcinolone acetonide or infracyanine green for idiopathic macular hole.
Ethics approval(s)Catholic University of Sacro Cuore Ethics Committee, 08 November 2010
Health condition(s) or problem(s) studiedIdiopathic macular hole
InterventionPatients were divided in two arms of 15 patients each.

Patients of the first arm underwent pars plana vitrectomy and internal limiting membrane peeling assisted by intravitreal injection of triamcinolone acetonide.

Patients of the second arm underwent pars plana vitrectomy and internal limiting membrane peeling assisted by staining with infracyanine green.
Intervention typeOther
Primary outcome measure(s)

1. Visual acuity measured with Snellen chart before surgery, 7 days and 1, 3, 6 and 12 months after surgery.
2. Anatomical outcomes and macular hole closure evaluated by spectral domain optical coherence tomography.
3. Focal electroretinography of the central 2 and 16 degrees of the retina measured before surgery, 1 and 7 days and 1, 3, 6 and 12 months after surgery.

Key secondary outcome measure(s)

Fundus microperimetry with MP-1 before surgery and 1, 3, 6 and 12 months after surgery

Completion date31/07/2012

Eligibility

Participant type(s)Patient
Age groupAdult
SexAll
Target sample size at registration30
Key inclusion criteriaFull thickness idiopathic macular hole (stage II, III or IV of Gass Classification) diagnosed and staged by slit-lamp fundus examination, using a 90-diopter lens and spectral domain optical coherence tomography
Key exclusion criteria1. Visual acuity worse than 1.0 (logMAR)
2. Previous macular surgery
3. Corneal opacities
4. Macular diseases other than macular hole
5. Optic nerve atrophy
6. Phakic patients
Date of first enrolment01/12/2010
Date of final enrolment31/07/2012

Locations

Countries of recruitment

  • Italy

Study participating centre

Largo Agostino Gemelli
Rome
00168
Italy

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes